Your browser doesn't support javascript.
Application of glucocorticoids in treatment of COVID-19.
Chinese Journal of Clinical Infectious Diseases ; 14(1):21-23, 2021.
Article in Chinese | EMBASE | ID: covidwho-2261585
ABSTRACT
The infection of 2019-nCoV can lead to overexpression of inflammatory factors, triggering cytokine storm and causing serious damage to the body. Glucocorticoids have anti-inflammatory properties and may be an effective treatment option. The use and dosage of glucocorticoids in coronavirus disease 2019 (COVID-19) remains controversial. This article reviews the theoretical basis, clinical evidence, debates and specific measures of glucocorticoids in the treatment of COVID-19, to provide reference for rational application of glucocorticoids in the future.Copyright © 2021 Chinese Medical Association
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: Chinese Journal: Chinese Journal of Clinical Infectious Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Language: Chinese Journal: Chinese Journal of Clinical Infectious Diseases Year: 2021 Document Type: Article